Moreover, in our previous analysis of TCGA RNA sequencing data from FLT3-ITD + AML patient samples (Wallace et al., 2017), miR-1-2 was highly upregulated in FLT3-ITD + patients (Figure 2B), consistent with miR-1 expression being clinically relevant. Here, FLT3 is linked to acute myeloid leukemia.